STOKStoke Therapeutics, Inc.

$33.10

Is it safe?

Can STOK take a bad year?

The deepest fall in STOK's price history on file is −95%; it is −14% below its high today.

16.54

Altman Z-score · distress below 1.8 · safe above 3 · safe zone, the balance sheet is not what threatens this one

Cash runway
2.3 years

Cash runway · burning $37M a quarter at the current rate

Annualised volatility
65%

Annualised volatility · three times the market's own swing

Worst drawdown on file
−95%

Worst drawdown on file · −14% today

Details
Cash and short-term investments
$344M
EBITDA, trailing twelve months
−$184M
Operating profit, trailing twelve months
−$185M
Annualised volatilitytwo years of daily moves
65%
Worst drawdown on file
−95%
Below its 52-week high
−14%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.